From:
`Sent:
`To:
`Subject:
`
`library
`Thursday, May 14, 2015 1:07 PM
`Fuller, Maegan A
`FW: 2000 PDR < <#31512-181246#> >
`
`Maegan,
`This is what customer service from PDR sent me.
`~charles
`
`From: PDR [mailto:CustomerService@pdr.net]
`Sent: Thursday, May 14, 2015 1:04PM
`To: Library
`Subject: 2000 PDR <<#31512-181246#>>
`
`Dear Valued Customer:
`
`Thank you for your interest in PDR. The 2000 PDR was published i_n November 1999 and distribution
`began in December 1999.
`
`Cordially, ·
`
`PDR Customer Service Department
`
`AboutPDR
`
`Trusted by generations ofhealthcare providers, PDR deliversinnovative health knowledge products and
`services that support prescribing decisions and patient adherence to improve health. As a leading provider of
`behavior-based prescription management programs, PDR provides event-driven and clinically relevant
`healthcare messaging through its patented process that improves patient compliance and outcomes, while
`preserving privacy. This network is made up of e-prescribing, electronic medical record (EMR), and electronic
`health record (EHR) applications, chain and independent pharmacies, and sponsors ofhealthcare-related
`education such as pharmaceutical manufacturers, health plans, payers, and pharmacy benefit managers. The
`Physicians' Desk Reference® suite of services provides healthcare professionals multichannel access to
`important drug information: the PDR®, the most recognized drug information reference available in the U.S.;
`interactive drug information services for EHR/EMR systems; digital communication services; PDR.net®; and
`mobilePDR®.
`
`------ Piease do not remove your unique tracking number! ------
`<<#31512-181246#>>
`
`This email and any of its contents may contain PDR Network, LLC proprietary Information, which is prlvileged, confidential, or subject to Copyright belanging to
`PDR Network, LLC. This emaills lntended solely for the use of the Individual or entity to which it is addrel)sed, lf you are not the intended recipient of tihis email,
`you are hereby notified that any dissemination, distribution, copying, or action Iaken ln relation to the contents of and attachments tothisemail is strictly prohibited
`and may be unlawful. lf you have received this email in error, notify thesender immediately and perma:nently delete·the original and any copy of this email.
`
`Dr. Reddy's Laboratories, Ltd., et al.
`V.
`Galderma Laboratories, lnc.
`IPR2015-__
`Exhibit 1014
`Exh. 1014